Synchrony Financial (NYSE:SYF) is expanding its CareCredit partnership with Planet DDS, integrating its financing into orthodontic and dental practice management platforms. This strategic move aims to streamline patient financing for higher-ticket treatments and embed CareCredit deeper into healthcare workflows, potentially influencing receivables and customer reach. Despite this expansion, Synchrony Financial’s stock is currently trading significantly below analyst targets and Simply Wall St’s fair value estimate, with forecasted earnings expected to decline over the next three years.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Synchrony Financial’s CareCredit Push Into Dental Workflows Meets Depressed Valuation
Synchrony Financial (NYSE:SYF) is expanding its CareCredit partnership with Planet DDS, integrating its financing into orthodontic and dental practice management platforms. This strategic move aims to streamline patient financing for higher-ticket treatments and embed CareCredit deeper into healthcare workflows, potentially influencing receivables and customer reach. Despite this expansion, Synchrony Financial’s stock is currently trading significantly below analyst targets and Simply Wall St’s fair value estimate, with forecasted earnings expected to decline over the next three years.